期刊文献+

福建省1987—2017年HIV/AIDS诊断病例生存时间和影响因素分析 被引量:22

Survival and its related factors among adolescent and adult HIV/AIDS patients in Fujian province, 1987 – 2017
原文传递
导出
摘要 目的了解福建省艾滋病病毒感染者/艾滋病(HIV/AIDS)病例生存状况的分布特征,探讨生存时间的影响因素。方法将1987年1月1日—2 017年12月31日符合条件的福建省HIV/AIDS诊断病例共计12 079例纳入研究队列,采用回顾性队列研究方法收集HIV/AIDS病例生存状况的相关信息,计算病例的全死因死亡率和标化死亡率。通过寿命表法和Kaplan-Meier法计算病例的生存率和生存时间,利用Cox比例风险模型探索病例生存时间的影响因素。结果福建省HIV/AIDS病例的全死因死亡率为5.37/100人.年(95%CI=5.10~5.64),标化全死因死亡率7.99/100人.年(95%CI=7.40~8.58)。HIV/AIDS病例的平均生存时间为17.0年(95%CI=16.1~17.9),1、5、10和15年的生存率分别为92%、82%、73%和68%。Cox比例风险模型分析显示,婚姻状况为已婚有配偶、离异或丧偶和不详的HIV/AIDS病例的死亡风险分别是未婚的1.248倍、1.481倍和1.914倍,确诊时年龄≥50岁、高中及以上文化程度、首次CD4+T淋巴细胞计数≥200个/mm3和接受抗病毒治疗的HIV/AIDS病例的死亡风险分别是15~49岁年龄组、初中及以下文化程度、首次CD4+T淋巴细胞计数<200个/mm3和未接受抗病毒治疗的2.466倍、0.501倍、0.357倍和0.146倍。结论近年来,福建省HIV/AIDS病例的全死因死亡率进一步降低,未婚、15~49岁年龄组、高中及以上文化程度、首次CD4+T淋巴细胞检测结果≥200个/mm3和接受抗病毒治疗的HIV/AIDS病例的死亡风险相对较低。 Objective To examine the situation and associated factors of survival among human immunodeficiency virus/acquired immune deficiency syndrome(HIV/AIDS)patients registered in Fujian province.Methods We collected data on 12 079 HIV/AIDS patients aged≥15 years at the diagnosis and registered in Fujian province from January 1, 1987 till December 31, 2017 for a retrospective cohort study. We calculated all-cause and standardized mortality rate of the patients. Life table and Kaplan-Meier method were applied to analyze survival rate and time of the patients. Cox proportional hazard model was used to explore factors related to the survival time.Results Among the patients, the all-cause and standardized mortality rate were 5.37(95% confidence interval [95% CI]: 5.10-5.64)and 7.99(95% CI: 7.40-8.58)per 100 person-years;the average survival time was 17(95% CI: 16.1-17.9)years;and the survival rate at 1, 5, 10, and 15 years were 92%, 82%, 73%, and 68%, respectively. The results of Cox proportional hazard analysis indicated that the patients being married or having a permanent heterosexual partner, being divorced or widowed, and with unknown marital status were at 1.248, 1.481, and 1.914 times higher probability of death compared to the unmarried patients;the patients aged≥50 years at the diagnosis had a 2.466 times higher probability of death than the patients aged 15-49 years at the diagnosis;while, in comparison with the patients with the education of junior high school and below, the initial CD4+ T lymphocyte cell count of<200 cells/mm3 at the diagnosis, and not receiving highly active anti-retroviral therapy(HAART), the patients with the education of senior high school and above, the initial CD4+ T lymphocyte cell count of≥200 cells/mm3, and having received HAART had significantly decreased probability of death, with the hazard risk of 0.501, 0.357, and 0.146 respectively.Conclusion The all-cause mortality of HIV/AIDS patients in Fujian province decreased in recent years;the patients being unmarried, aged 15-49 years, with the education of senior high school and above, with the initial CD4+ T lymphocyte cell count of≥200 cells/mm3 at the diagnosis, and receiving HAART were at relatively lower probability of death.
作者 陈亮 连巧龄 张明雅 潘蕴蛟 吴韶彬 刘美增 林丽 CHEN Liang;LIAN Qiao-ling;ZHANG Ming-ya(Department of Health Intervention in High-Risk Population, Fujian Provincial Center for Disease Control and Prevention, Fuzhou, Fujian Province 350001, China)
出处 《中国公共卫生》 CAS CSCD 北大核心 2018年第12期1603-1607,共5页 Chinese Journal of Public Health
关键词 人类免疫缺陷病毒 全死因死亡率 生存分析 Cox比例风险模型分析 human immunodeficiency virus all-cause mortality rate survival analysis Cox proportional hazard model analysis
  • 相关文献

参考文献10

二级参考文献113

  • 1吕繁,张丽芬,王哲,乔晓春,李东民.中国中部地区两县既往有偿献血人群艾滋病回顾性队列研究[J].中华流行病学杂志,2005,26(5):311-313. 被引量:30
  • 2张福杰,文毅,于兰,马烨,潘捷,赵燕.艾滋病的抗病毒治疗与我国的免费治疗现状[J].科技导报,2005,23(7):24-29. 被引量:106
  • 3王爱霞,王福生,王清玥,王健,冯铁建,卢洪洲,孙洪清,孙永涛,叶寒辉,李太生,李兴旺,刘正印,邢玉兰,何云,汪宁,吴昊,吴南屏,张福杰,周曾全,宫恩聪,赵红心,赵敏,唐小平,徐莲芝,徐小元,曹韵贞,康来仪,蒋岩,蔡卫平,樊庆泊,潘孝彰.艾滋病诊疗指南[J].中华传染病杂志,2006,24(2):133-144. 被引量:632
  • 4姚璇,詹发先,彭国平.湖北省艾滋病抗病毒治疗终止原因分析[J].中国艾滋病性病,2006,12(6):495-497. 被引量:27
  • 5张福杰,王健,王福生,等.国家免费艾滋病抗病毒药物治疗手册[M].3版.北京:人民卫生出版社,2012:183-185.
  • 6Staszewski S,Morales-Ramirez J,Tashima KT,et al.Efavirenz plus zidovudine and lamivudine,efavirenz plus indinavir,and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults.Study 006 Team[J].N Engl J Med,1999,341 (25):1865-1873.
  • 7Gallant JE,Staszewski S,Pozniak AL,et al.Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviralnaive patients:a 3-year randomized trial[J].JAMA,2004,292 (2):191-201.
  • 8Zhang F,Dou Z,Yu L,et al.The effect of highly active antiretroviral therapy on mortality among HIV-infected former plasma donors in China[J].Clin Infect Dis,2008,47 (6):825-833.
  • 9Rossi SM,Maluf EC,Carvalho DS,et al.Impact of antiretroviral therapy under different treatment regimens[J].Rev Panam Salud Publica,2012,32 (2):117-123.
  • 10UNAIDS Reference Group on Estimates,Modeling and Projections.Improved methods and assumptions for estimation of the HIV/AIDS epidemic and its impact:recommendations of the UNAIDS Reference Group on Estimates,Modeling and Projections[J].AIDS,2002,16(9):w1-14.

共引文献234

同被引文献157

引证文献22

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部